Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107774142 | 10777414 | 2 | F | 20160809 | 20150209 | 20160816 | EXP | CA-TEVA-539651USA | TEVA | 70.00 | YR | F | Y | 74.00000 | KG | 20160816 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107774142 | 10777414 | 1 | PS | TREANDA | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 150 MG MILLIGRAM(S),1 IN 28 D | 22249 | 5.3571 | MG | INTRAVENOUS INFUSION | |||||||
| 107774142 | 10777414 | 2 | SS | TREANDA | BENDAMUSTINE HYDROCHLORIDE | 1 | 22249 | ||||||||||||
| 107774142 | 10777414 | 3 | SS | TREANDA | BENDAMUSTINE HYDROCHLORIDE | 1 | 22249 | ||||||||||||
| 107774142 | 10777414 | 4 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 630 MG MILLIGRAM(S),1 IN 28 D) | 0 | 22.5 | MG | INTRAVENOUS INFUSION | |||||||
| 107774142 | 10777414 | 5 | SS | RITUXAN | RITUXIMAB | 1 | 0 | ||||||||||||
| 107774142 | 10777414 | 6 | SS | RITUXAN | RITUXIMAB | 1 | 0 | ||||||||||||
| 107774142 | 10777414 | 7 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 250 (SERETIDE PRESSURISED INHALATION) | 0 | BID | |||||||||
| 107774142 | 10777414 | 8 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | Oral | 800 MILLIGRAM DAILY; | 0 | 400 | MG | BID | |||||||
| 107774142 | 10777414 | 9 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MILLIGRAM DAILY; | 0 | 25 | MG | QD | |||||||
| 107774142 | 10777414 | 10 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Oral | 1-2 TABS Q6H PRN | 0 | TABLET | |||||||||
| 107774142 | 10777414 | 11 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | 0 | ||||||||||||
| 107774142 | 10777414 | 12 | C | RAMIPRIL. | RAMIPRIL | 1 | 5 MILLIGRAM DAILY; | 0 | 5 | MG | QD | ||||||||
| 107774142 | 10777414 | 13 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | .125 MILLIGRAM DAILY; | 0 | .125 | MG | QD | ||||||||
| 107774142 | 10777414 | 14 | C | TECTA(PANTOPRAZOLE MAGNESIUM)(Gastro-resistant tablet) | 2 | Oral | 80 MILLIGRAM DAILY; | 0 | 40 | MG | ENTERIC-COATED TABLET | BID | |||||||
| 107774142 | 10777414 | 15 | C | VALIUM | DIAZEPAM | 1 | 10 MILLIGRAM DAILY; | 0 | 5 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107774142 | 10777414 | 1 | Malignant neoplasm progression |
| 107774142 | 10777414 | 2 | Lymphadenopathy |
| 107774142 | 10777414 | 3 | B-cell lymphoma |
| 107774142 | 10777414 | 4 | Malignant neoplasm progression |
| 107774142 | 10777414 | 5 | Lymphadenopathy |
| 107774142 | 10777414 | 6 | B-cell lymphoma |
| 107774142 | 10777414 | 7 | Product used for unknown indication |
| 107774142 | 10777414 | 8 | Product used for unknown indication |
| 107774142 | 10777414 | 9 | Product used for unknown indication |
| 107774142 | 10777414 | 10 | Product used for unknown indication |
| 107774142 | 10777414 | 11 | Product used for unknown indication |
| 107774142 | 10777414 | 12 | Product used for unknown indication |
| 107774142 | 10777414 | 13 | Product used for unknown indication |
| 107774142 | 10777414 | 14 | Product used for unknown indication |
| 107774142 | 10777414 | 15 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107774142 | 10777414 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107774142 | 10777414 | Anaemia | |
| 107774142 | 10777414 | Neutropenia | |
| 107774142 | 10777414 | Pancytopenia | |
| 107774142 | 10777414 | Respiratory distress | |
| 107774142 | 10777414 | Thrombocytopenia | |
| 107774142 | 10777414 | Upper respiratory tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107774142 | 10777414 | 1 | 2013 | 2013 | 0 | |
| 107774142 | 10777414 | 7 | 2014 | 0 | ||
| 107774142 | 10777414 | 8 | 2014 | 0 | ||
| 107774142 | 10777414 | 9 | 2014 | 0 | ||
| 107774142 | 10777414 | 10 | 2014 | 0 | ||
| 107774142 | 10777414 | 12 | 2014 | 0 | ||
| 107774142 | 10777414 | 13 | 2014 | 0 | ||
| 107774142 | 10777414 | 14 | 2014 | 0 | ||
| 107774142 | 10777414 | 15 | 2014 | 0 |